Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Local Minneapolis Star and Tribune Reporter James Walsh Cracks the need for SEC disclosures from Device Manufacturers in the Myxo File Part III

January 31, 2013

CHICAGO, Jan. 31, 2013 /PRNewswire/ – The Myxo File Part I and part II reveals
the truth surrounding the Clinical trials testing heart devices between
2003-2009. Soon after Mr. James Walsh published in the Minneapolis Star
and Tribune, the full disclosure by St. Jude to investors, he reported:

(Photo: http://photos.prnewswire.com/prnh/20130131/TO530)

“The U.S. Food and Drug Administration has sent a warning letter to St.
Jude Medical regarding manufacturing processes at a facility in
Southern California, St. Jude and the FDA have confirmed and reported
January 14, 2013″.

The Myxo File Part III was recently written and published on Kindle
Direct Publishing linking the importance of full disclosure by Medical
Device Manufacturers and Medical Device Safety for Citizens across the
world. Providential Meeting with the President of the United States is
described in the Biographical story to make device safety a top issue
for US hospitals across the United States.

Nalini M. Rajamannan, MD is the author of the Myxo File Part I, Part II,
and Part III, which has published the original documents supporting
this release on Amazon and Kindle Direct Publishing, Rajamannan is the
CEO of Concie Valve LLC.

SOURCE ConcieValve LLP


Source: PR Newswire